Kelly Owen, Cusack Siobhan, Jewell Christopher, Cashman Kevin D
Department of Food and Nutritional Sciences, University College, Cork, Republic of Ireland.
Br J Nutr. 2003 Oct;90(4):743-50. doi: 10.1079/bjn2003951.
The effect of polyunsaturated fatty acids (PUFA), in particular conjugated linoleic acid (CLA), on Ca and bone metabolism is unclear. In a 2x2 factorial design study, forty male 4-week-old rats were fed a control diet containing 70 g added fat (soyabean oil (SBO; n-6 PUFA-rich diet) or menhaden oil-safflower oil (MSO; n-3 PUFA-rich diet))/kg diet with 0 or 10 g CLA/kg for 8 weeks. Ex vivo prostaglandin E2 biosynthesis by bone organ culture was significantly higher (P<0.001) in rats consuming SBO compared with MSO, irrespective of CLA. Addition of the CLA treatment to either diet further lowered (P<0.05) ex vivo prostaglandin E2 production. Neither PUFA type nor CLA altered circulating or femoral mRNA levels of osteocalcin (a marker of bone formation) or insulin-like growth factor-I (a mediator of bone metabolism). While urinary pyridinium crosslinks levels (markers of bone resorption) were unaffected by CLA irrespective of PUFA type, they were significantly higher (P<0.05) in rats consuming SBO compared with MSO irrespective of CLA. Net fractional (%) and absolute (mg) Ca absorption were significantly (P<0.01 and P<0.05 respectively) higher in CLA-supplemented than unsupplemented animals fed on the n-3 PUFA-rich diet, whereas CLA had no effect in animals fed the n-6 PUFA-rich diet. There was no effect of CLA supplementation on bone mineral mass. In conclusion, CLA supplementation over 8 weeks appeared to enhance Ca absorption in young growing rats fed an n-3 PUFA-rich diet, but had no measurable effect on bone metabolism or bone mass over this time frame.
多不饱和脂肪酸(PUFA),尤其是共轭亚油酸(CLA),对钙和骨代谢的影响尚不清楚。在一项2×2析因设计研究中,将40只4周龄雄性大鼠分为四组,分别喂食含70 g添加脂肪(大豆油(SBO;富含n-6多不饱和脂肪酸的饮食)或鲱鱼油-红花油(MSO;富含n-3多不饱和脂肪酸的饮食))/千克饮食且添加0或10 g CLA/千克的对照饮食,持续8周。无论是否添加CLA,食用SBO的大鼠骨器官培养物中前列腺素E2的体外生物合成均显著高于(P<0.001)食用MSO的大鼠。在两种饮食中添加CLA处理均进一步降低了(P<0.05)前列腺素E2的体外产生量。PUFA类型和CLA均未改变骨钙素(骨形成标志物)或胰岛素样生长因子-I(骨代谢介质)的循环水平或股骨mRNA水平。无论PUFA类型如何,CLA均不影响尿吡啶交联水平(骨吸收标志物),但无论是否添加CLA,食用SBO的大鼠尿吡啶交联水平均显著高于(P<0.05)食用MSO的大鼠。在富含n-3多不饱和脂肪酸的饮食中,添加CLA的动物的钙净吸收率(%)和绝对吸收量(mg)显著高于(分别为P<0.01和P<0.05)未添加CLA的动物,而CLA对富含n-6多不饱和脂肪酸饮食的动物没有影响。补充CLA对骨矿物质质量没有影响。总之,在8周的时间里,补充CLA似乎增强了喂食富含n-3多不饱和脂肪酸饮食的幼龄生长大鼠的钙吸收,但对骨代谢或骨质量没有可测量的影响。